Busan
South Korea
8
2024-10-03
4
2019-12-31
These are the the leading inventors for applications assigned to SILLAJEN, INC.:
SILLAJEN, INC. based in Busan, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Cancer Treatments
#2 | 2024-08-01CANCER TREATMENTS
#3 | 2022-12-01Immune Assay for Monitoring Response to Oncolytic Vaccinia Virus and Uses Thereof
#4 | 2020-03-19ONCOLYTIC VACCINIA VIRUS AND CHECKPOINT INHIBITOR COMBINATION THERAPY
#5 | 2018-10-25 ✅ Patent 10,517,910 granted on 2019-12-31Compositions and methods for viral embolization
#6 | 2018-09-27 ✅ Patent 10,646,524 granted on 2020-05-12Modified oncolytic vaccinia viruses expressing a cytokine and a car-boxylesterase and methods of use thereof
#7 | 2018-08-02 ✅ Patent 10,434,169 granted on 2019-10-08Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
#8 | 2015-02-05 ✅ Patent 9,919,047 granted on 2018-03-20Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
Also check out SILLAJEN, INC.'s (Busan, South Korea) applicant profile with 5 patent applications submitted.
87333 ⎘